ResearcherFirst Hospital of China Medical UniversityActive in the last 2 years
Zhe Liu
Matched on ORCID iD 0000-0002-2536-4180; OpenAlex author ID A5013834850. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- Natural Compounds as Potential Therapeutics for Pancreatic Cancer: A Narrative Review. Last author DOI 10.2174/0113892002393013250812093213↗
- ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis. Co-author DOI 10.1038/s41416-022-01927-y↗
- Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting. Co-author DOI 10.1002/jcsm.12692↗
- Gene expression profile analysis of pancreatic cancer based on microarray data. First author DOI 10.3892/mmr.2016.5021↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruixia Du · 1 shared paper, 2025 · strength 0.33
- Xingda Lin · 1 shared paper, 2025 · strength 0.33
- Shengyu Yang · 2 shared papers, 2021–2022 · strength 0.25
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated … DOI 10.1002/jcsm.12692↗
- Xiuchao Wang · 2 shared papers, 2021–2022 · strength 0.25
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated … DOI 10.1002/jcsm.12692↗
- Song Gao · 2 shared papers, 2021–2022 · strength 0.25
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated … DOI 10.1002/jcsm.12692↗
- Chuntao Gao · 2 shared papers, 2021–2022 · strength 0.25
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated … DOI 10.1002/jcsm.12692↗
- Tiansuo Zhao · 2 shared papers, 2021–2022 · strength 0.25
- Paper ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/… DOI 10.1038/s41416-022-01927-y↗
- Paper Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated … DOI 10.1002/jcsm.12692↗
- Fanjie Jin · 1 shared paper, 2022 · strength 0.13
- Chongbiao Huang · 1 shared paper, 2022 · strength 0.13
- Jihui Hao · 1 shared paper, 2022 · strength 0.13
- Wenrun Cai · 1 shared paper, 2022 · strength 0.13
- Jing Liu · 1 shared paper, 2022 · strength 0.13
- Liangliang Wu · 1 shared paper, 2021 · strength 0.12
- Jie Dong · 1 shared paper, 2021 · strength 0.12
- Jihui Hao · 1 shared paper, 2021 · strength 0.12
- Xingda Wu · 1 shared paper, 2016 · strength 0.08
- Jin Long · 1 shared paper, 2016 · strength 0.08
- Yuanhong Xu · 1 shared paper, 2016 · strength 0.08
- Chunlin Ge · 1 shared paper, 2016 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.